Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Science (New York, N.Y.)|October 1, 2017
Tsunami-driven rafting: Transoceanic species dispersal and implications for marine biogeographyJames T Carlton, John W Chapman, Jonathan B Geller, et al.
Cancer Management and Research|June 6, 2017
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trialIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Annals of Neurology|February 1, 1997
Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosisM E Cudkowicz, D McKenna-Yasek, P E Sapp, et al.
Blood|October 1, 1989
A two-step timed sequential treatment for acute myelocytic leukemiaR B Geller, P J Burke, J E Karp, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2018
Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in RatsSaadet Inan, Toby K Eisenstein, Mia N Watson, et al.
The Analyst|August 31, 2013
Enhanced imaging of developed fingerprints using mass spectrometry imagingM J Bailey, M Ismail, S Bleay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1996
Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imagingC Y Wong, E B Geller, E Q Chen, et al.
British Journal of Pharmacology|June 21, 2019
Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB1 and CB2 receptorsXiaohong Chen, Alan Cowan, Saadet Inan, et al.
Life Sciences|October 7, 2021
Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depressionSaadet Inan, Xiaohong Chen, Eric M Eisenstein, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Pageof 25